Pure Global AI
NCT06317584Not yet recruiting

Empowerment-based Complementary and Alternative Medicine (ECAM)

The Establishment of Empowerment-based Complementary and Alternative Medicine (ECAM) Educational Program to Improve Complementary and Alternative Medicine(CAM) Health Literacy in Patients With Diabetes: Dilemma Analysis, Integration Into Practice and Outcome Evaluation
Chang Gung University of Science and TechnologyClinicalTrials.govother
Verified
Study focus
Disease/Condition
Diabetes
Drug/Device/Intervention
Experimental: Empowerment Application for CAM Health Education
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Chang Gung University of Science and Technology
Location
Taoyuan City, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jul 31, 2025
Enrollment
86 participants
Primary outcome

Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire,Quality of life questionnaire,Diabetes Empowerment scale

Summary

This phase study will use a randomized trial method to evaluate the performance of the ECAM
 educational app in the promotion of CAM health literacy and communication among patients with
 diabetes.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06317584
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06317584 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung University of Science and Technology and is currently Not yet recruiting. The study focuses on Diabetes. Target enrollment is 86 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.